Skip to main content
Published locations for mRECIST objective response and early tumor shrinkage predict survival in sorafenib-treated HCC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
mRECIST objective response and early tumor shrinkage predict survival in sorafenib-treated HCC
User login
Username
Password
Reset your password
/content/mrecist-objective-response-and-early-tumor-shrinkage-predict-survival-sorafenib-treated-0
/gihepnews/article/250921/hepatocellular-carcinoma/mrecist-objective-response-and-early-tumor